publication date: Aug. 12, 2011
Genentech: ODAC Lacks Expertise, Impartiality; FDA: Company’s Proposal Unscientific Fadlo Khuri Named Editor-in-Chief of ACS Journal Cancer NCCN Launches Outcomes Improvement Program Download PDF Documents found in this issue can be downloaded here
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.